{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:26:32Z","timestamp":1793330792966,"version":"4.5.0"},"reference-count":52,"publisher":"The Endocrine Society","issue":"3","license":[{"start":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T00:00:00Z","timestamp":1597708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Australian Government National Health and Medical Research Council Early Career Fellowship","award":["1143333"],"award-info":[{"award-number":["1143333"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>As the number of transgender (trans) people (including those who are binary and\/or nonbinary identified) seeking gender-affirming hormone therapy rises, endocrinologists are increasingly asked to assist with interpretation of laboratory tests. Many common laboratory tests such as hemoglobin, iron studies, cardiac troponin, and creatinine are affected by sex steroids or body size. We seek to provide a summary of the impact of feminizing and masculinizing hormone therapy on common laboratory tests and an approach to interpretation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Cases<\/jats:title>\n                  <jats:p>Case scenarios discussed include 1) hemoglobin and hematocrit in a nonbinary person undergoing masculinizing hormone therapy; 2) estimation of glomerular filtration rate in a trans woman at risk of contrast-induced nephropathy; 3) prostate-specific antigen (PSA) in a trans woman; and 4) chest pain in a trans man with a cardiac troponin concentration between the reported male and female reference ranges.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The influence of exogenous gender-affirming hormone therapy on fat and muscle distribution and other physiological changes determines interpretation of laboratory tests that have sex-specific differences. In addition to affirmative practice to ensure a patient\u2019s name, gender, and pronoun are used appropriately, we propose that once individuals have commenced gender-affirming hormone therapy, the reference range of the affirmed gender be reported (and specified by treating clinicians) except for PSA or cardiac troponin, which are dependent on organ size. While suggestions may be challenging to implement, they also represent an opportunity to lead best practice to improve the quality of care and experiences of healthcare for all trans people.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgaa546","type":"journal-article","created":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T18:09:57Z","timestamp":1597774197000},"page":"893-901","source":"Crossref","is-referenced-by-count":52,"title":["Approach to Interpreting Common Laboratory Pathology Tests in Transgender Individuals"],"prefix":"10.1210","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5257-5525","authenticated-orcid":false,"given":"Ada S","family":"Cheung","sequence":"first","affiliation":[{"name":"Trans Health Research group, Department of Medicine (Austin Health), The University of Melbourne, Victoria, Australia"},{"name":"Department of Endocrinology, Austin Health, Heidelberg, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2455-3155","authenticated-orcid":false,"given":"Hui Yin","family":"Lim","sequence":"additional","affiliation":[{"name":"Diagnostics Haematology, Northern Pathology Victoria, Northern Health, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teddy","family":"Cook","sequence":"additional","affiliation":[{"name":"ACON Health, Surry Hills, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sav","family":"Zwickl","sequence":"additional","affiliation":[{"name":"Trans Health Research group, Department of Medicine (Austin Health), The University of Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Ginger","sequence":"additional","affiliation":[{"name":"Trans Health Research group, Department of Medicine (Austin Health), The University of Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cherie","family":"Chiang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Austin Health, Heidelberg, Victoria, Australia"},{"name":"Department of Diabetes and Endocrinology, Royal Melbourne Hospital, Victoria, Australia"},{"name":"Department of Pathology, Royal Melbourne Hospital, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D","family":"Zajac","sequence":"additional","affiliation":[{"name":"Trans Health Research group, Department of Medicine (Austin Health), The University of Melbourne, Victoria, Australia"},{"name":"Department of Endocrinology, Austin Health, Heidelberg, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2020,8,18]]},"reference":[{"issue":"1","key":"2021122117001105400_CIT0001","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/trgh.2018.0019","article-title":"Sociodemographic and Clinical Characteristics of Transgender Adults in Australia","volume":"3","author":"Cheung","year":"2018","journal-title":"Transgend Health."},{"issue":"5","key":"2021122117001105400_CIT0002","first-page":"919","article-title":"Age- and sex-specific reference limits for creatinine, cystatin C and the estimated glomerular filtration rate","volume":"50","author":"Hannemann","year":"2011","journal-title":"Clin Chem Lab Med."},{"issue":"10","key":"2021122117001105400_CIT0003","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1373\/clinchem.2019.306431","article-title":"Reference Values for 30 Common Biochemistry Analytes Across 5 Different Analyzers in Neonates and Children 30 Days to 18 Years of Age","volume":"65","author":"Hoq","year":"2019","journal-title":"Clin Chem."},{"issue":"5","key":"2021122117001105400_CIT0004","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1071\/SH17067","article-title":"Epidemiology of gender dysphoria and transgender identity","volume":"14","author":"Zucker","year":"2017","journal-title":"Sex Health."},{"issue":"10","key":"2021122117001105400_CIT0005","doi-asserted-by":"crossref","first-page":"e0204606","DOI":"10.1371\/journal.pone.0204606","article-title":"Proportion of adults in the general population of Stockholm County who want gender-affirming medical treatment","volume":"13","author":"\u00c5hs","year":"2018","journal-title":"Plos One."},{"issue":"1","key":"2021122117001105400_CIT0006","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/trgh.2015.0008","article-title":"A Systematic Review of the Effects of Hormone Therapy on Psychological Functioning and Quality of Life in Transgender Individuals","volume":"1","author":"White Hughto","year":"2016","journal-title":"Transgend Health."},{"issue":"2","key":"2021122117001105400_CIT0007","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1530\/EJE-17-0496","article-title":"Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: results from a multicenter prospective study","volume":"178","author":"Klaver","year":"2018","journal-title":"Eur J Endocrinol."},{"issue":"2","key":"2021122117001105400_CIT0008","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1530\/EJE-14-0586","article-title":"Body composition, bone turnover, and bone mass in trans men during testosterone treatment: 1-year follow-up data from a prospective case-controlled study (ENIGI)","volume":"172","author":"Van Caenegem","year":"2015","journal-title":"Eur J Endocrinol."},{"issue":"6","key":"2021122117001105400_CIT0009","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/cen.13607","article-title":"Impact of cross-sex hormone therapy on bone mineral density and body composition in transwomen","volume":"88","author":"Fighera","year":"2018","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"4","key":"2021122117001105400_CIT0010","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jsxm.2020.01.012","article-title":"European Society for Sexual Medicine Position Statement \u201cAssessment and Hormonal Management in Adolescent and Adult Trans People, With Attention for Sexual Function and Satisfaction\u201d","volume":"17","author":"T\u2019Sjoen","year":"2020","journal-title":"J Sex Med."},{"issue":"3","key":"2021122117001105400_CIT0011","doi-asserted-by":"crossref","first-page":"127","DOI":"10.5694\/mja2.50259","article-title":"Position statement on the hormonal management of adult transgender and gender diverse individuals","volume":"211","author":"Cheung","year":"2019","journal-title":"Med J Aust."},{"issue":"11","key":"2021122117001105400_CIT0012","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine Treatment of Gender-Dysphoric\/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline","volume":"102","author":"Hembree","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2021122117001105400_CIT0013","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9061609","article-title":"Hormonal treatment strategies tailored to non-binary transgender individuals","volume":"9","author":"Cocchetti","year":"2020","journal-title":"J Clin Med"},{"issue":"4","key":"2021122117001105400_CIT0014","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1016\/S2468-2667(20)30032-3","article-title":"Gender-concordant identity documents and mental health among transgender adults in the USA: a cross-sectional study","volume":"5","author":"Scheim","year":"2020","journal-title":"Lancet Public Health."},{"key":"2021122117001105400_CIT0015","doi-asserted-by":"crossref","first-page":"100595","DOI":"10.1016\/j.ssmph.2020.100595","article-title":"Legal gender marker and name change is associated with lower negative emotional response to gender-based mistreatment and improve mental health outcomes among trans populations","volume":"11","author":"Restar","year":"2020","journal-title":"SSM Popul Health."},{"issue":"1","key":"2021122117001105400_CIT0016","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1373\/clinchem.2018.292730","article-title":"Impact of Hormone Therapy on Laboratory Values in Transgender Patients","volume":"65","author":"SoRelle","year":"2019","journal-title":"Clin Chem."},{"key":"2021122117001105400_CIT0017","doi-asserted-by":"crossref","first-page":"2042018820924543","DOI":"10.1177\/2042018820924543","article-title":"Relationships between body mass index with oral estradiol dose and serum estradiol concentration in transgender adults undergoing feminising hormone therapy","volume":"11","author":"Nolan","year":"2020","journal-title":"Ther Adv Endocrinol Metab."},{"issue":"2","key":"2021122117001105400_CIT0018","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1210\/jc.2017-01559","article-title":"Effects of Sex Hormone Treatment on the Metabolic Syndrome in Transgender Individuals: Focus on Metabolic Cytokines","volume":"103","author":"Auer","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2021122117001105400_CIT0019","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1373\/jalm.2018.027078","article-title":"Common Hormone Therapies Used to Care for Transgender Patients Influence Laboratory Results","volume":"3","author":"Humble","year":"2019","journal-title":"J Appl Lab Med."},{"issue":"2","key":"2021122117001105400_CIT0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-0030-1255074","article-title":"Body composition and bone mineral density in male-to-female transsexuals during cross-sex hormone therapy using gonadotrophin-releasing hormone agonist","volume":"119","author":"Mueller","year":"2011","journal-title":"Exp Clin Endocrinol Diabetes."},{"key":"2021122117001105400_CIT0021","article-title":"Prevalence of polycythaemia with different formulations of testosterone therapy in transmasculine individuals","author":"Nolan","year":"2020","journal-title":"Internal Med J"},{"issue":"2","key":"2021122117001105400_CIT0022","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/lgbt.2019.0260","article-title":"Lower Serum Estradiol Levels in Assigned Female at Birth Transgender People with Initiation of Testosterone Therapy: Results from the European Network for the Investigation of Gender Incongruence","volume":"7","author":"Defreyne","year":"2020","journal-title":"LGBT Health."},{"issue":"8","key":"2021122117001105400_CIT0023","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/jsm.12571","article-title":"Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence","volume":"11","author":"Wierckx","year":"2014","journal-title":"J Sex Med."},{"issue":"4","key":"2021122117001105400_CIT0024","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jpsychores.2015.02.001","article-title":"Concomitant psychiatric problems and hormonal treatment induced metabolic syndrome in gender dysphoria individuals: a 2 year follow-up study","volume":"78","author":"Colizzi","year":"2015","journal-title":"J Psychosom Res."},{"issue":"2","key":"2021122117001105400_CIT0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.amjmed.2013.10.009","article-title":"Interpreting laboratory results in transgender patients on hormone therapy","volume":"127","author":"Roberts","year":"2014","journal-title":"Am J Med."},{"issue":"4","key":"2021122117001105400_CIT0026","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4158\/EP15950.OR","article-title":"Metabolic effects of hormone therapy in transgender patients","volume":"22","author":"Fernandez","year":"2016","journal-title":"Endocr Pract."},{"issue":"3","key":"2021122117001105400_CIT0027","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/andr.12485","article-title":"Prospective evaluation of hematocrit in gender-affirming hormone treatment: results from European Network for the Investigation of Gender Incongruence","volume":"6","author":"Defreyne","year":"2018","journal-title":"Andrology."},{"issue":"5","key":"2021122117001105400_CIT0028","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2796.1993.tb00783.x","article-title":"Haematocrit: a predictor of cardiovascular mortality?","volume":"234","author":"Erikssen","year":"1993","journal-title":"J Intern Med."},{"issue":"3","key":"2021122117001105400_CIT0029","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1161\/HYPERTENSIONAHA.112.191510","article-title":"Hematocrit predicts long-term mortality in a nonlinear and sex-specific manner in hypertensive adults","volume":"60","author":"Paul","year":"2012","journal-title":"Hypertension."},{"issue":"1","key":"2021122117001105400_CIT0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cgh.2013.07.019","article-title":"Factors that affect serum levels of ferritin in Australian adults and implications for follow-up","volume":"12","author":"McKinnon","year":"2014","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"9","key":"2021122117001105400_CIT0031","doi-asserted-by":"crossref","first-page":"525","DOI":"10.5694\/j.1326-5377.2010.tb04038.x","article-title":"Diagnosis and management of iron deficiency anaemia: a clinical update","volume":"193","author":"Pasricha","year":"2010","journal-title":"Med J Aust."},{"issue":"5","key":"2021122117001105400_CIT0032","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/sj.ijo.0801561","article-title":"Association of serum ferritin and indices of body fat distribution and obesity in Mexican American men\u2013the Third National Health and Nutrition Examination Survey","volume":"25","author":"Gillum","year":"2001","journal-title":"Int J Obes Relat Metab Disord."},{"issue":"2","key":"2021122117001105400_CIT0033","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s12011-014-0051-3","article-title":"Sex differences in iron status and hepcidin expression in rats","volume":"160","author":"Kong","year":"2014","journal-title":"Biol Trace Elem Res."},{"issue":"5","key":"2021122117001105400_CIT0034","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/cen.13130","article-title":"Effect of testosterone on hepcidin, ferroportin, ferritin and iron binding capacity in patients with hypogonadotropic hypogonadism and type 2 diabetes","volume":"85","author":"Dhindsa","year":"2016","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"5","key":"2021122117001105400_CIT0035","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1053\/j.ajkd.2013.12.006","article-title":"GFR estimation: from physiology to public health","volume":"63","author":"Levey","year":"2014","journal-title":"Am J Kidney Dis."},{"issue":"6","key":"2021122117001105400_CIT0036","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1172\/JCI102020","article-title":"Comparison of the constant infusion and urine collection techniques for the measurement of renal function","volume":"27","author":"BERGER","year":"1948","journal-title":"J Clin Invest."},{"issue":"3","key":"2021122117001105400_CIT0037","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/j.ajkd.2007.11.018","article-title":"Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3418 individuals with CKD","volume":"51","author":"Stevens","year":"2008","journal-title":"Am J Kidney Dis."},{"issue":"3","key":"2021122117001105400_CIT0038","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.yhbeh.2007.05.012","article-title":"Cross-sex pattern of bone mineral density in early onset gender identity disorder","volume":"52","author":"Haraldsen","year":"2007","journal-title":"Horm Behav."},{"issue":"3","key":"2021122117001105400_CIT0039","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4239\/wjd.v11.i3.66","article-title":"Effects of gender-affirming hormone therapy on insulin resistance and body composition in transgender individuals: A systematic review","volume":"11","author":"Spanos","year":"2020","journal-title":"World J Diabetes."},{"issue":"9","key":"2021122117001105400_CIT0040","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa412","article-title":"Prostate cancer incidence under androgen deprivation: nationwide cohort study in trans women receiving hormone treatment","volume":"105","author":"de Nie","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2021122117001105400_CIT0041","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/cen.13835","article-title":"Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals-A systematic review","volume":"89","author":"McFarlane","year":"2018","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"9","key":"2021122117001105400_CIT0042","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1373\/clinchem.2017.271684","article-title":"Impact of Sex on Cardiac Troponin Concentrations-A Critical Appraisal","volume":"63","author":"Eggers","year":"2017","journal-title":"Clin Chem."},{"key":"2021122117001105400_CIT0043","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.clinbiochem.2020.05.014","article-title":"Analytical and clinical characterization of a novel high-sensitivity cardiac troponin assay in a United States population","volume":"83","author":"Christenson","year":"2020","journal-title":"Clin Biochem."},{"issue":"1","key":"2021122117001105400_CIT0044","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1373\/clinchem.2016.255109","article-title":"Cardiac Troponin Assays: Guide to Understanding Analytical Characteristics and Their Impact on Clinical Care","volume":"63","author":"Apple","year":"2017","journal-title":"Clin Chem."},{"issue":"6","key":"2021122117001105400_CIT0045","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0735-1097(02)01712-6","article-title":"Gender differences and normal left ventricular anatomy in an adult population free of hypertension. A cardiovascular magnetic resonance study of the Framingham Heart Study Offspring cohort","volume":"39","author":"Salton","year":"2002","journal-title":"J Am Coll Cardiol."},{"issue":"12","key":"2021122117001105400_CIT0046","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1210\/jc.2012-1597","article-title":"Polycystic ovary syndrome is associated with higher left ventricular mass index: the CARDIA women\u2019s study","volume":"97","author":"Wang","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2021122117001105400_CIT0047","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1161\/01.CIR.92.3.380","article-title":"Relationship of cardiovascular risk factors to echocardiographic left ventricular mass in healthy young black and white adult men and women. The CARDIA study. Coronary Artery Risk Development in Young Adults","volume":"92","author":"Gardin","year":"1995","journal-title":"Circulation."},{"issue":"5","key":"2021122117001105400_CIT0048","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/andr.12382","article-title":"Effects of testosterone therapy on BMI, blood pressure, and laboratory profile of transgender men: a systematic review","volume":"5","author":"Velho","year":"2017","journal-title":"Andrology."},{"issue":"3","key":"2021122117001105400_CIT0049","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/AOG.0000000000000692","article-title":"Effects of cross-sex hormone treatment on transgender women and men","volume":"125","author":"Deutsch","year":"2015","journal-title":"Obstet Gynecol."},{"issue":"12","key":"2021122117001105400_CIT0050","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1111\/jsm.12698","article-title":"Effects of three different testosterone formulations in female-to-male transsexual persons","volume":"11","author":"Pelusi","year":"2014","journal-title":"J Sex Med."},{"issue":"11","key":"2021122117001105400_CIT0051","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1210\/jc.2017-01643","article-title":"Sex Steroids and Cardiovascular Outcomes in Transgender Individuals: A Systematic Review and Meta-Analysis","volume":"102","author":"Maraka","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"2021122117001105400_CIT0052","doi-asserted-by":"crossref","first-page":"E1306","DOI":"10.1210\/jc.2013-4470","article-title":"Systemic delivery of estradiol, but not testosterone or progesterone, alters very low density lipoprotein-triglyceride kinetics in postmenopausal women","volume":"99","author":"Smith","year":"2014","journal-title":"J Clin Endocrinol Metab."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaa546\/36238145\/dgaa546.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/3\/893\/41832304\/dgaa546.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/3\/893\/41832304\/dgaa546.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T17:20:13Z","timestamp":1640107213000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/106\/3\/893\/5893977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,18]]},"references-count":52,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,8,18]]},"published-print":{"date-parts":[[2021,3,8]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaa546","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,3,1]]},"published":{"date-parts":[[2020,8,18]]}}}